Multimodal therapy of metachronous anaplastic pancreatic carcinomas including two pancreatic resections
-
- ITO Takashi
- Department of Surgery, Otsu Red Cross Hospital
-
- KITO Yoshinori
- Department of Surgery, Yamatotakada Municipal Hospital
-
- KOZU Takumi
- Department of Surgery, Otsu Red Cross Hospital
-
- ABE Yusuke
- Department of Surgery, Otsu Red Cross Hospital
-
- KANEDA Akihiro
- Department of Surgery, Otsu Red Cross Hospital
-
- NAKAMURA Naoto
- Department of Surgery, Otsu Red Cross Hospital
-
- MATSUBAYASHI Jun
- Department of Surgery, Otsu Red Cross Hospital
-
- NAKAYAMA Yusuke
- Department of Surgery, Otsu Red Cross Hospital
-
- KITAGUCHI Kazuhiko
- Department of Surgery, Otsu Red Cross Hospital
-
- URA Katsuaki
- Department of Surgery, Otsu Red Cross Hospital
-
- TOYODA Eiji
- Department of Surgery, Otsu Red Cross Hospital
-
- OE Hideaki
- Department of Surgery, Otsu Red Cross Hospital
-
- HIROSE Tetsuro
- Department of Surgery, Otsu Red Cross Hospital
-
- DOI Ryuichiro
- Department of Surgery, Otsu Red Cross Hospital
Bibliographic Information
- Other Title
-
- 2回の膵切除手術によって長期生存した退形成性膵管癌の異時性重複発生の1例
Search this article
Abstract
<p>A 70-year-old man was diagnosed with carcinoma of the pancreatic head because of worsening diabetes, and pancreatoduodenectomy was performed. The tumor was 9mm in diameter (TS1 in JPS classification), and histopathological examination revealed an osteoclast-like giant cell-type anaplastic pancreatic carcinoma. Twenty-nine months after surgery, abdominal CT scan revealed a 22-mm mass in the residual pancreatic body with a dilated pancreatic duct, indicating another tumor. Residual pancreatectomy (total pancreatectomy) was then performed. Histopathologically, a spindle cell-type anaplastic carcinoma was found that was different from the subtype of the initial anaplastic carcinoma. We regarded this as a new lesion, not a recurrence of the initial one. This is the first report in Japan of metachronous anaplastic pancreatic carcinomas with different subtypes. Anaplastic pancreatic carcinoma is very rare and is associated with a poor prognosis. The current patient achieved long-term survival with multimodal therapy including two pancreatic resections. Aggressive surgical treatment can contribute to the prognosis of patients with this disease.</p>
Journal
-
- Suizo
-
Suizo 35 (5), 439-446, 2020-10-30
Japan Pancreas Society
- Tweet
Details 詳細情報について
-
- CRID
- 1391693801398423424
-
- NII Article ID
- 130007931561
-
- ISSN
- 18812805
- 09130071
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed